Everence Capital Management’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
BCM
Everence Capital Management's TBI Position: Q4 2022 in Review
Everence Capital Management sold out of Trueblue (TBI) in Q4 2022, closing a stake of 22,230 shares — an estimated $424K sold.
Everence Capital Management first reported a position in TBI in Q2 2021 and held it in 6 quarters. The position peaked at $797K in Q1 2022. 164 funds tracked by Wall St. Rank hold TBI as of Q4 2022.
- Everence Capital Management reported no remaining Trueblue position as of Q4 2022 after selling out during the quarter.
- Everence Capital Management sold 22,230 Trueblue shares in Q4 2022, an estimated $424K.
- Everence Capital Management first reported a position in Trueblue in Q2 2021 and held it in 6 quarters.
- Everence Capital Management's Trueblue position peaked at $797K in Q1 2022.
- 164 funds tracked by Wall St. Rank held Trueblue as of Q4 2022.
Based on Everence Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.